Thalidomide for type 1 cryoglobulinemic vasculopathy

Archives of Dermatology

Volumn 142, Issue 8, 2006, Pages 972-974

  Sampson, Alia ^a   Callen, Jeffrey P ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; THALIDOMIDE; ANGIOGENESIS INHIBITOR;

ADOLESCENT; ANAMNESIS; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CRYOGLOBULINEMIA; DRUG TOLERANCE; FEMALE; HUMAN; LABORATORY TEST; PHYSICAL EXAMINATION; PRIORITY JOURNAL; VASCULAR DISEASE; ADULT; DIFFERENTIAL DIAGNOSIS; LEG; ORAL DRUG ADMINISTRATION; PATHOLOGY; SKIN BLOOD VESSEL DISORDER;

ADMINISTRATION, ORAL; ADULT; ANGIOGENESIS INHIBITORS; CRYOGLOBULINEMIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LOWER EXTREMITY; SKIN DISEASES, VASCULAR; THALIDOMIDE;

EID: 33747605554     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.142.8.972     Document Type: Article

References (7)

1. Cohen SJ, Pittelkow MR, Su WPD. Cutaneous manifestations of cryoglobulinemia: clinical and histopathological study of seventy two patients. J Am Acad Dermatol. 1991;25:21-27.
2. Dimopoulos MA, Merlini G, Leblond V, Anagnostopoulos A, Alexanian R. How we treat Waldenstrom's macroglobulinemia. Haematologica. 2005;90:117-125.
3. Vila AT, Barnadas MA, Ballarin J, et al. Cutaneous ulcers with type I cryoglobulinemia treated with plasmapheresis. Eur J Dermatol. 2004;14:186-189.
4. Vacca A, Scavelli C, Montefusco V, et al. Thalidomide downregulates angiogenic genes in bone marrow endothelial cells of patients with active multiple myeloma. J Clin Oncol. 2005;23:5334-5346.
5. Caradonna S, Jacobe H. Thalidomide as a potential treatment for scleromyxedema. Arch Dermatol. 2004;140:277-280.
6. Sinisalo M, Hietaharju A, Sauranen J, Wirta O. Thalidomide in POEMS syndrome: case report. Am J Hematol. 2004;76:66-68.
7. Cem Ar M, Soysal T, Hatemi G, Salihoglu A, Yazici H, Ulku B. Successful management of cryoglobulinemia-induced leukocytoclastic vasculitis with thalidomide in a patient with multiple myeloma. Ann Hematol. 2005;84:609-613.